First-line treatment for CIDP: a new piece of the puzzle

Lancet Neurol. 2012 Jun;11(6):478-9. doi: 10.1016/S1474-4422(12)70101-1. Epub 2012 May 10.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage*
  • Female
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage*
  • Male
  • Methylprednisolone / administration & dosage*
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / drug therapy*

Substances

  • Anti-Inflammatory Agents
  • Immunoglobulins, Intravenous
  • Methylprednisolone